Taurolidine Lock Solution in the Prevention of Catheter Related Bacteremia

PHASE3CompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
BacteremiaNeoplasms
Interventions
DEVICE

Taurolock

When not in use the childrens tunneled central venous catheters are locked with the liquid Taurolock instead of heparin.

DEVICE

Heparin

When not in use the childrens tunneled central venous catheters are locked with heparin

Trial Locations (1)

8200

Childrens Department of Oncology A4, Aarhus Universityhospital, Skejby, Århus N

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Danish Child Cancer Foundation

OTHER

collaborator

TauroPharm

INDUSTRY

lead

Aarhus University Hospital

OTHER